We are live on ! Find out more
LMAT icon

LeMaitre Vascular

142 hedge funds and large institutions have $448M invested in LeMaitre Vascular in 2017 Q4 according to their latest regulatory filings, with 22 funds opening new positions, 52 increasing their positions, 49 reducing their positions, and 28 closing their positions.

New
Increased
Maintained
Reduced
Closed

2.64% more ownership

Funds ownership: 70.36%73.01% (+2.6%)

6% more repeat investments, than reductions

Existing positions increased: 52 | Existing positions reduced: 49

4% less funds holding

Funds holding: 148142 (-6)

10% less capital invested

Capital invested by funds: $501M → $448M (-$52.4M)

21% less first-time investments, than exits

New positions opened: 22 | Existing positions closed: 28

33% less funds holding in top 10

Funds holding in top 10: 32 (-1)

100% less call options, than puts

Call options by funds: $0 | Put options by funds: $280K

Holders
142
Holders Change
-6
Holders Change %
-4.05%
% of All Funds
3.22%
Holding in Top 10
2
Holding in Top 10 Change
-1
Holding in Top 10 Change %
-33.33%
% of All Funds
0.05%
New
22
Increased
52
Reduced
49
Closed
28
Calls
Puts
$280K
Net Calls
-$280K
Net Calls Change
-$282K
Name Holding Trade Value Shares
Change
Change in
Stake
Principal Financial Group
26
Principal Financial Group
Iowa
$3.82M -$1.3K -38 -0%
BIA
27
Biondo Investment Advisors
Pennsylvania
$3.71M +$3.99M +116,450 New
DCM
28
Driehaus Capital Management
Illinois
$3.57M -$2.01M -58,603 -34%
PAM
29
Panagora Asset Management
Massachusetts
$3.22M -$1.34M -39,138 -28%
Morgan Stanley
30
Morgan Stanley
New York
$3.22M -$2.2M -64,156 -39%
Federated Hermes
31
Federated Hermes
Pennsylvania
$3.16M -$2.18M -63,781 -39%
AG
32
Algert Global
California
$2.77M +$57.3K +1,673 +2%
Bank of America
33
Bank of America
North Carolina
$2.62M -$2.22M -64,670 -44%
RHJA
34
Rice Hall James & Associates
California
$2.28M -$131K -3,830 -5%
PCM
35
Perkins Capital Management
Minnesota
$2.19M -$287K -8,375 -11%
Charles Schwab
36
Charles Schwab
California
$2.1M +$19.7K +574 +0.9%
GC
37
Guggenheim Capital
Illinois
$2.04M +$309K +9,034 +16%
BG
38
Bahl & Gaynor
Ohio
$2.03M +$28.1K +820 +1%
RhumbLine Advisers
39
RhumbLine Advisers
Massachusetts
$1.93M +$73.2K +2,138 +4%
Goldman Sachs
40
Goldman Sachs
New York
$1.59M -$461K -13,449 -21%
California Public Employees Retirement System
41
California Public Employees Retirement System
California
$1.58M -$90.5K -2,642 -5%
FLAM
42
First Light Asset Management
Minnesota
$1.47M -$23.9K -697 -1%
AllianceBernstein
43
AllianceBernstein
Tennessee
$1.43M +$566K +16,530 +58%
CAM
44
Congress Asset Management
Massachusetts
$1.37M +$89.4K +2,611 +6%
WCM
45
Wedge Capital Management
North Carolina
$1.33M
MERSOM
46
Municipal Employees' Retirement System of Michigan
Michigan
$1.3M +$493K +14,380 +54%
Comerica Bank
47
Comerica Bank
Texas
$1.23M +$425K +12,400 +53%
Deutsche Bank
48
Deutsche Bank
Germany
$1.22M +$246K +7,176 +23%
FG
49
Formula Growth
Quebec, Canada
$1.21M
Assenagon Asset Management
50
Assenagon Asset Management
Luxembourg
$1.18M +$1.27M +37,182 New

LMAT Hedge Fund Activity: Q4 2017 in Review

142 of the 4,409 institutional investors tracked by Wall St. Rank reported a position in LeMaitre Vascular (LMAT) for Q4 2017, worth a combined $448M — down 10% from $501M a quarter earlier.

Sellers outnumbered buyers: 28 funds closed out of LMAT and 22 opened new positions — a net loss of 6 holders — while 49 trimmed existing stakes and 52 added.

The largest buyer was Epoch Investment Partners, opening a new position worth an estimated $25.4M. The largest seller was Bogle Investment Management, exiting entirely with an estimated $4.66M sold.

  • 142 institutional investors held LeMaitre Vascular (LMAT) as of Q4 2017, down from 148 in Q3 2017.
  • Funds reported $448M of LeMaitre Vascular stock for Q4 2017, down 10% quarter-over-quarter.
  • 22 funds opened new LeMaitre Vascular positions in Q4 2017 and 28 closed out, a net change of -6 holders.
  • The largest LeMaitre Vascular buyer in Q4 2017 was Epoch Investment Partners, an estimated $25.4M added.
  • The largest LeMaitre Vascular seller in Q4 2017 was Bogle Investment Management, an estimated $4.66M sold.

Based on aggregated 13F filings for Q4 2017.